Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

45.58
Delayed Data
As of Apr 29
 -1.32 / -2.81%
Today’s Change
31.25
Today|||52-Week Range
58.46
-19.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues19.8M0.000.000.00
 
 
Depreciation And Amortization244.0K251.0K244.0K270.0K
 
 
 
 
 
 
Operating ExpensesGross Income---251.0K-244.0K-270.0K
 
 
 
 
General Expenses21.8M25.1M35.6M30.5M
 
 
 
 
 
Research And Development16.6M18.7M24.4M21.8M
 
 
 
 
 
Total Operating Expenses22.1M25.3M35.8M30.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.3M-25.3M-35.8M-30.7M
 
 
 
 
 
Other Expenses1.1M829.0K828.0K849.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.2M-24.0M-34.4M-29.3M
 
 
 
 
 
Net Income-1.2M-24.0M-34.4M-29.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS80.3M85.5M85.9M86.2M
 
 
 
 
 
Shares To Calculate EPS Diluted80.3M85.5M85.9M86.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.01-$0.28-$0.40-$0.34
 
 
 
 
 
EPS Diluted-$0.01-$0.28-$0.40-$0.34